KCNQ1 Antibodies

Santa Cruz Biotechnology features a diverse variety of KCNQ1 monoclonal antibodies for research focused on understanding KCNQ1 protein function. KCNQ1 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KCNQ1, also known as potassium voltage-gated channel subfamily Q member 1, is crucial for cardiac and epithelial cell function, playing a significant role in the regulation of ion transport and maintaining the electrical stability of the heart. Mutations in the KCNQ1 gene are associated with long QT syndrome and other cardiac arrhythmias, highlighting its importance in cardiovascular health. KCNQ1 is involved in the secretion of gastric acid, making it vital for digestive processes. Research using KCNQ1 monoclonal antibodies has revealed important insights into ion channel regulation and cellular signaling pathways. Understanding KCNQ1's role in maintaining cardiac rhythm has led to breakthroughs in treating heart conditions. Investigating KCNQ1's function in different tissues continues to uncover new therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of KCNQ1's role in human health and disease.